These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Natural killer cells. Kimber I Med Lab Sci; 1985 Jan; 42(1):60-77. PubMed ID: 2580211 [No Abstract] [Full Text] [Related]
23. Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC). Targan S; Dorey F Ann N Y Acad Sci; 1980; 350():121-9. PubMed ID: 6165267 [No Abstract] [Full Text] [Related]
24. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
25. [Circulating serum interferon and its effect on human natural killer cell activity]. Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580 [No Abstract] [Full Text] [Related]
26. Clinical immunological and immunogenetical aspects of neurological diseases. Péterfalvi A Ideggyogy Sz; 2010 Jan; 63(1-2):52-60. PubMed ID: 20420125 [No Abstract] [Full Text] [Related]
27. Modulation of immune lysis of tumor cells by interferon. Ng AK; Imai K; Pellegrino MA; Vitiello A; Indiveri F; Wilson BS; Ferrone S Biomembranes; 1983; 11():313-39. PubMed ID: 6187384 [No Abstract] [Full Text] [Related]
28. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group. Haahr S; Møller-Larsen A; Pedersen E Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564 [TBL] [Abstract][Full Text] [Related]
29. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232 [TBL] [Abstract][Full Text] [Related]
30. [Regulation of the activity of human natural killer cells by autologous interferon]. Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561 [No Abstract] [Full Text] [Related]
33. What is the relevance of the various immunomodulatory effects of interferons? Morris A Ann Inst Pasteur Immunol (1985); 1985; 136D(1):79-81. PubMed ID: 2415043 [No Abstract] [Full Text] [Related]
34. NK susceptibility varies inversely with target cell class I HLA antigen expression. Storkus WJ; Howell DN; Salter RD; Dawson JR; Cresswell P J Immunol; 1987 Mar; 138(6):1657-9. PubMed ID: 3819393 [No Abstract] [Full Text] [Related]
35. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis. Uchida A; Maida EM; Lenzhofer R; Micksche M Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561 [TBL] [Abstract][Full Text] [Related]